Compare SUSMED, Inc. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0.04%
- The company has been able to generate a Return on Equity (avg) of 0.04% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.04%
3
Negative results in Mar 26
4
Risky -
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 10,762 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.96
-12.08%
2.62
Revenue and Profits:
Net Sales:
139 Million
(Quarterly Results - Mar 2026)
Net Profit:
-60 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.36%
0%
-17.36%
6 Months
-0.85%
0%
-0.85%
1 Year
33.22%
0%
33.22%
2 Years
39.62%
0%
39.62%
3 Years
-50.49%
0%
-50.49%
4 Years
2.91%
0%
2.91%
5 Years
0%
0%
0.0%
SUSMED, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
55.14%
EBIT Growth (5y)
7.91%
EBIT to Interest (avg)
-215.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.09
Tax Ratio
0.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.04%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.12
EV to EBIT
-47.20
EV to EBITDA
-48.57
EV to Capital Employed
90.31
EV to Sales
27.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-191.32%
ROE (Latest)
-6.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
139.40
45.40
207.05%
Operating Profit (PBDIT) excl Other Income
-57.00
-151.20
62.30%
Interest
0.00
0.00
Exceptional Items
-0.70
-0.30
-133.33%
Consolidate Net Profit
-59.70
-152.00
60.72%
Operating Profit Margin (Excl OI)
-423.20%
-3,368.60%
294.54%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 207.05% vs -1.09% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 60.72% vs -25.93% in Dec 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
463.00
342.60
35.14%
Operating Profit (PBDIT) excl Other Income
-291.50
-359.00
18.80%
Interest
0.00
0.00
Exceptional Items
-2.50
0.60
-516.67%
Consolidate Net Profit
-298.40
-357.40
16.51%
Operating Profit Margin (Excl OI)
-646.80%
-1,065.40%
41.86%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 35.14% vs -35.44% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 16.51% vs -604.93% in Jun 2024
About SUSMED, Inc. 
SUSMED, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






